

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.21798488 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.71787193 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.71787193 |
| 4 | positive regulation of interferon-alpha production (GO:0032727) | 4.64432974 |
| 5 | regulation of RIG-I signaling pathway (GO:0039535) | 4.47458297 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.38356078 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.38356078 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.38356078 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.38356078 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.38356078 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.38356078 |
| 12 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.36920834 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.35413246 |
| 14 | regulation of interferon-alpha production (GO:0032647) | 4.35030784 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.30813702 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.30813702 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.03516901 |
| 18 | cellular response to virus (GO:0098586) | 4.03002965 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 3.95169252 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.92697420 |
| 21 | cellular response to type I interferon (GO:0071357) | 3.92048662 |
| 22 | type I interferon signaling pathway (GO:0060337) | 3.92048662 |
| 23 | response to interferon-alpha (GO:0035455) | 3.91295994 |
| 24 | response to type I interferon (GO:0034340) | 3.90053282 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.88979556 |
| 26 | detection of other organism (GO:0098543) | 3.86429420 |
| 27 | piRNA metabolic process (GO:0034587) | 3.83646675 |
| 28 | detection of bacterium (GO:0016045) | 3.75117014 |
| 29 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.75052525 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.55823327 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.53482467 |
| 32 | regulation of T cell tolerance induction (GO:0002664) | 3.52587616 |
| 33 | positive regulation of interferon-beta production (GO:0032728) | 3.51841089 |
| 34 | cellular response to interferon-alpha (GO:0035457) | 3.49058637 |
| 35 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.47168029 |
| 36 | regulation of mononuclear cell migration (GO:0071675) | 3.44192794 |
| 37 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.43635640 |
| 38 | T cell migration (GO:0072678) | 3.41273269 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.36788639 |
| 40 | defense response to protozoan (GO:0042832) | 3.35005808 |
| 41 | germinal center formation (GO:0002467) | 3.34114068 |
| 42 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.31540162 |
| 43 | natural killer cell mediated immunity (GO:0002228) | 3.31540162 |
| 44 | detection of external biotic stimulus (GO:0098581) | 3.29120131 |
| 45 | regulation of antigen processing and presentation (GO:0002577) | 3.28448244 |
| 46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.28083951 |
| 47 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.23122904 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.19936708 |
| 49 | response to protozoan (GO:0001562) | 3.17423463 |
| 50 | regulation of tolerance induction (GO:0002643) | 3.16821439 |
| 51 | detection of molecule of bacterial origin (GO:0032490) | 3.14394691 |
| 52 | negative regulation of viral genome replication (GO:0045071) | 3.13501316 |
| 53 | leukocyte aggregation (GO:0070486) | 3.11659245 |
| 54 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.08226308 |
| 55 | response to peptidoglycan (GO:0032494) | 3.05139218 |
| 56 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.04853715 |
| 57 | regulation of female gonad development (GO:2000194) | 3.03622354 |
| 58 | myeloid dendritic cell activation (GO:0001773) | 3.02558034 |
| 59 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.97865337 |
| 60 | macrophage activation involved in immune response (GO:0002281) | 2.97690829 |
| 61 | growth hormone receptor signaling pathway (GO:0060396) | 2.97680576 |
| 62 | urea cycle (GO:0000050) | 2.96078815 |
| 63 | urea metabolic process (GO:0019627) | 2.96078815 |
| 64 | negative regulation of lipid storage (GO:0010888) | 2.96077812 |
| 65 | regulation of cholesterol storage (GO:0010885) | 2.94738479 |
| 66 | female gamete generation (GO:0007292) | 2.94089984 |
| 67 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91628859 |
| 68 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.90756708 |
| 69 | response to interferon-gamma (GO:0034341) | 2.89520768 |
| 70 | cellular response to exogenous dsRNA (GO:0071360) | 2.88660154 |
| 71 | positive regulation of humoral immune response (GO:0002922) | 2.88519741 |
| 72 | regulation of type 2 immune response (GO:0002828) | 2.88480831 |
| 73 | B cell mediated immunity (GO:0019724) | 2.87466372 |
| 74 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.86845482 |
| 75 | regulation of macrophage chemotaxis (GO:0010758) | 2.86731830 |
| 76 | negative regulation of innate immune response (GO:0045824) | 2.86217491 |
| 77 | positive regulation of tolerance induction (GO:0002645) | 2.85796871 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 2.84749036 |
| 79 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.84327647 |
| 80 | detection of biotic stimulus (GO:0009595) | 2.83976888 |
| 81 | cellular extravasation (GO:0045123) | 2.82396189 |
| 82 | mitotic chromosome condensation (GO:0007076) | 2.81797489 |
| 83 | interferon-gamma secretion (GO:0072643) | 2.81649440 |
| 84 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.80041040 |
| 85 | T-helper 1 type immune response (GO:0042088) | 2.79895892 |
| 86 | regulation of regulatory T cell differentiation (GO:0045589) | 2.78289324 |
| 87 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.78105640 |
| 88 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.77879983 |
| 89 | response to host immune response (GO:0052572) | 2.77879983 |
| 90 | response to host (GO:0075136) | 2.77582698 |
| 91 | response to host defenses (GO:0052200) | 2.77582698 |
| 92 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.77582698 |
| 93 | regulation of interferon-beta production (GO:0032648) | 2.76416379 |
| 94 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.76229972 |
| 95 | regulation of interleukin-12 production (GO:0032655) | 2.75512613 |
| 96 | negative thymic T cell selection (GO:0045060) | 2.74984580 |
| 97 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.74931692 |
| 98 | granulocyte activation (GO:0036230) | 2.74677008 |
| 99 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.73599577 |
| 100 | lymphocyte chemotaxis (GO:0048247) | 2.72287446 |
| 101 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.72114000 |
| 102 | macrophage activation (GO:0042116) | 2.71713559 |
| 103 | regulation of hypersensitivity (GO:0002883) | 2.71491625 |
| 104 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.71083113 |
| 105 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.69877993 |
| 106 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.69768466 |
| 107 | regulation of activation of Janus kinase activity (GO:0010533) | 2.68975318 |
| 108 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.68584983 |
| 109 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.67955581 |
| 110 | tolerance induction (GO:0002507) | 2.66699216 |
| 111 | positive regulation of defense response to virus by host (GO:0002230) | 2.66445898 |
| 112 | neutrophil activation (GO:0042119) | 2.66418480 |
| 113 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.66146283 |
| 114 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.65071432 |
| 115 | dendritic cell differentiation (GO:0097028) | 2.63661295 |
| 116 | positive regulation of B cell differentiation (GO:0045579) | 2.63653010 |
| 117 | dendritic cell chemotaxis (GO:0002407) | 2.63048730 |
| 118 | regulation of necroptotic process (GO:0060544) | 2.63009619 |
| 119 | negative T cell selection (GO:0043383) | 2.62884955 |
| 120 | low-density lipoprotein particle clearance (GO:0034383) | 2.62172011 |
| 121 | nitrogen cycle metabolic process (GO:0071941) | 2.60547180 |
| 122 | neutrophil activation involved in immune response (GO:0002283) | 2.59203870 |
| 123 | NIK/NF-kappaB signaling (GO:0038061) | 2.57753879 |
| 124 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.52023805 |
| 125 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.50631837 |
| 126 | positive regulation of interleukin-12 production (GO:0032735) | 2.49347355 |
| 127 | cellular response to growth hormone stimulus (GO:0071378) | 2.48344096 |
| 128 | regulation of defense response to virus by host (GO:0050691) | 2.47891285 |
| 129 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.46950571 |
| 130 | histone H2A monoubiquitination (GO:0035518) | 2.46128586 |
| 131 | myeloid dendritic cell differentiation (GO:0043011) | 2.44177603 |
| 132 | positive regulation of T cell apoptotic process (GO:0070234) | 2.42121624 |
| 133 | complement activation, alternative pathway (GO:0006957) | 2.41758440 |
| 134 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.41424294 |
| 135 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.41085787 |
| 136 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.40664688 |
| 137 | protein carboxylation (GO:0018214) | 2.40664688 |
| 138 | meiotic cell cycle (GO:0051321) | 2.40663876 |
| 139 | response to interferon-beta (GO:0035456) | 2.40163440 |
| 140 | positive regulation of antigen processing and presentation (GO:0002579) | 2.38774313 |
| 141 | plasma lipoprotein particle clearance (GO:0034381) | 2.38030234 |
| 142 | defense response to virus (GO:0051607) | 2.37030876 |
| 143 | positive regulation of type 2 immune response (GO:0002830) | 2.36762248 |
| 144 | microglial cell activation (GO:0001774) | 2.35460420 |
| 145 | regulation of response to interferon-gamma (GO:0060330) | 2.35442992 |
| 146 | striated muscle atrophy (GO:0014891) | 2.32596676 |
| 147 | cellular response to interferon-gamma (GO:0071346) | 2.32205547 |
| 148 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.31903434 |
| 149 | response to muramyl dipeptide (GO:0032495) | 2.30463709 |
| 150 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.30128364 |
| 151 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.29135593 |
| 152 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.27775521 |
| 153 | DNA damage induced protein phosphorylation (GO:0006975) | 2.27650282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.64211467 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.47239439 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.07282422 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.68038238 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40819340 |
| 6 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.24937011 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.15286184 |
| 8 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.05468070 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.05105901 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.01408483 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69627039 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68879981 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.62736920 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.59212511 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.54727575 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.43613651 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.38879082 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33763941 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.26531060 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.24940339 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.19013256 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.14281103 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.14034350 |
| 24 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.97298085 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96744438 |
| 26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.94150805 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.85169418 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.83376390 |
| 29 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.79170662 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.75215093 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.70869355 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68322147 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67614643 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.66633364 |
| 35 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.58643934 |
| 36 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.56515900 |
| 37 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.52439754 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.51896992 |
| 39 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50481526 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49254779 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.48332224 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.48228852 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44803499 |
| 44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.44302730 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43509736 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.42249688 |
| 47 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.41978999 |
| 48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.40386285 |
| 49 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.36388941 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.33284413 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32403362 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31913341 |
| 53 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31109659 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30912070 |
| 55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.27990390 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27114160 |
| 57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25685486 |
| 58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24556140 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24411765 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24335730 |
| 61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23609731 |
| 62 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.23199890 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22604165 |
| 64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20340172 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19900762 |
| 66 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19792144 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19255056 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15649364 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13746068 |
| 70 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.13455642 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12628117 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11499017 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11447332 |
| 74 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11140252 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10959836 |
| 76 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10675527 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10470387 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10163161 |
| 79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09438183 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05591373 |
| 81 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.05205010 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04909658 |
| 83 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04275450 |
| 84 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.02759387 |
| 85 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01976977 |
| 86 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01762897 |
| 87 | * MYB_26560356_Chip-Seq_TH2_Human | 1.01712650 |
| 88 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01534488 |
| 89 | MYB_26560356_Chip-Seq_TH1_Human | 1.01239544 |
| 90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99037504 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98760488 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98035710 |
| 93 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97992220 |
| 94 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97816476 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97284272 |
| 96 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96506872 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95762536 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95755492 |
| 99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95699860 |
| 100 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.95199015 |
| 101 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94506249 |
| 102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94415666 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94405234 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94380202 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94113948 |
| 106 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93239635 |
| 107 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92737029 |
| 108 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92717255 |
| 109 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.92185250 |
| 110 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.92029850 |
| 111 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90460662 |
| 112 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.90227565 |
| 113 | MAF_26560356_Chip-Seq_TH1_Human | 0.89963793 |
| 114 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.88266123 |
| 115 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87645279 |
| 116 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.86772350 |
| 117 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86475234 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86023608 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85962696 |
| 120 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85185714 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84875151 |
| 122 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84703164 |
| 123 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84552357 |
| 124 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84389113 |
| 125 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84174987 |
| 126 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83548152 |
| 127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83203934 |
| 128 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81377551 |
| 129 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.81101122 |
| 130 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.78097444 |
| 131 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77677229 |
| 132 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.77056026 |
| 133 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76606808 |
| 134 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.75655650 |
| 135 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.75440274 |
| 136 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75122694 |
| 137 | SPI1_23127762_ChIP-Seq_K562_Human | 0.74738742 |
| 138 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74042201 |
| 139 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.73555151 |
| 140 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.73309811 |
| 141 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73243616 |
| 142 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.72338012 |
| 143 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.71757612 |
| 144 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.71305375 |
| 145 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.71194948 |
| 146 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.70795313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.21920519 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.05166953 |
| 3 | MP0009840_abnormal_foam_cell | 3.04537218 |
| 4 | MP0005451_abnormal_body_composition | 2.96217399 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.86071717 |
| 6 | MP0009785_altered_susceptibility_to | 2.62446261 |
| 7 | MP0003718_maternal_effect | 2.51339011 |
| 8 | MP0003724_increased_susceptibility_to | 2.36548532 |
| 9 | MP0003646_muscle_fatigue | 2.30102537 |
| 10 | MP0003436_decreased_susceptibility_to | 2.25502333 |
| 11 | MP0006082_CNS_inflammation | 2.20681958 |
| 12 | MP0005365_abnormal_bile_salt | 2.08903592 |
| 13 | MP0004510_myositis | 2.04571490 |
| 14 | MP0003303_peritoneal_inflammation | 2.03428698 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.00365689 |
| 16 | MP0003763_abnormal_thymus_physiology | 1.98371301 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 1.95622852 |
| 18 | MP0000685_abnormal_immune_system | 1.95284293 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 1.94792418 |
| 20 | MP0005310_abnormal_salivary_gland | 1.85970755 |
| 21 | MP0005025_abnormal_response_to | 1.85393290 |
| 22 | MP0002419_abnormal_innate_immunity | 1.82338522 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.80101644 |
| 24 | MP0005408_hypopigmentation | 1.76871599 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.76673086 |
| 26 | MP0003252_abnormal_bile_duct | 1.76596936 |
| 27 | MP0005387_immune_system_phenotype | 1.73699656 |
| 28 | MP0001790_abnormal_immune_system | 1.73699656 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.72050767 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.71724501 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.67842739 |
| 32 | MP0009764_decreased_sensitivity_to | 1.66088056 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.56527267 |
| 34 | MP0004947_skin_inflammation | 1.55616739 |
| 35 | MP0010307_abnormal_tumor_latency | 1.55520010 |
| 36 | MP0005395_other_phenotype | 1.52925615 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.52004785 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.50963882 |
| 39 | MP0001800_abnormal_humoral_immune | 1.48274708 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.44827439 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.43544117 |
| 42 | MP0002723_abnormal_immune_serum | 1.43436511 |
| 43 | MP0004185_abnormal_adipocyte_glucose | 1.42224562 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.41846648 |
| 45 | MP0005671_abnormal_response_to | 1.39989327 |
| 46 | MP0008260_abnormal_autophagy | 1.38261898 |
| 47 | MP0004782_abnormal_surfactant_physiolog | 1.35185288 |
| 48 | MP0003453_abnormal_keratinocyte_physiol | 1.34520621 |
| 49 | MP0002006_tumorigenesis | 1.34500804 |
| 50 | MP0008469_abnormal_protein_level | 1.34470507 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.32230224 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.31747139 |
| 53 | MP0000609_abnormal_liver_physiology | 1.31361615 |
| 54 | MP0002429_abnormal_blood_cell | 1.30500694 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.29908894 |
| 56 | MP0001873_stomach_inflammation | 1.29560988 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.29249990 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.28958263 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.28958263 |
| 60 | MP0002722_abnormal_immune_system | 1.27827976 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.25834441 |
| 62 | MP0003866_abnormal_defecation | 1.24778969 |
| 63 | MP0010329_abnormal_lipoprotein_level | 1.24766710 |
| 64 | MP0005166_decreased_susceptibility_to | 1.22373267 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.22114601 |
| 66 | MP0008004_abnormal_stomach_pH | 1.20865198 |
| 67 | MP0003448_altered_tumor_morphology | 1.20359688 |
| 68 | MP0001819_abnormal_immune_cell | 1.18675467 |
| 69 | MP0009763_increased_sensitivity_to | 1.16808950 |
| 70 | MP0001119_abnormal_female_reproductive | 1.16634800 |
| 71 | MP0000343_altered_response_to | 1.15357562 |
| 72 | MP0002420_abnormal_adaptive_immunity | 1.12800527 |
| 73 | MP0001915_intracranial_hemorrhage | 1.12309219 |
| 74 | MP0003828_pulmonary_edema | 1.10117618 |
| 75 | MP0005257_abnormal_intraocular_pressure | 1.09088648 |
| 76 | MP0010368_abnormal_lymphatic_system | 1.09076486 |
| 77 | MP0001851_eye_inflammation | 1.09065658 |
| 78 | MP0003699_abnormal_female_reproductive | 1.08617930 |
| 79 | MP0003186_abnormal_redox_activity | 1.08593043 |
| 80 | MP0009278_abnormal_bone_marrow | 1.07919519 |
| 81 | MP0003300_gastrointestinal_ulcer | 1.06874919 |
| 82 | MP0002405_respiratory_system_inflammati | 1.04223126 |
| 83 | MP0003091_abnormal_cell_migration | 1.02505269 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 1.00832019 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 1.00156601 |
| 86 | MP0000703_abnormal_thymus_morphology | 0.99248199 |
| 87 | MP0002254_reproductive_system_inflammat | 0.99177518 |
| 88 | MP0005164_abnormal_response_to | 0.97909139 |
| 89 | MP0003690_abnormal_glial_cell | 0.96270718 |
| 90 | MP0000604_amyloidosis | 0.95313648 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.94810632 |
| 92 | MP0003195_calcinosis | 0.94577874 |
| 93 | MP0004883_abnormal_blood_vessel | 0.94321498 |
| 94 | MP0005083_abnormal_biliary_tract | 0.92598823 |
| 95 | MP0005023_abnormal_wound_healing | 0.91505371 |
| 96 | MP0004808_abnormal_hematopoietic_stem | 0.90773563 |
| 97 | MP0001663_abnormal_digestive_system | 0.90623030 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.90119465 |
| 99 | MP0000716_abnormal_immune_system | 0.89626194 |
| 100 | MP0000579_abnormal_nail_morphology | 0.89589915 |
| 101 | MP0004264_abnormal_extraembryonic_tissu | 0.86495767 |
| 102 | MP0001666_abnormal_nutrient_absorption | 0.86459020 |
| 103 | MP0003075_altered_response_to | 0.85826519 |
| 104 | MP0000767_abnormal_smooth_muscle | 0.84554615 |
| 105 | MP0000598_abnormal_liver_morphology | 0.83898202 |
| 106 | MP0002398_abnormal_bone_marrow | 0.83806595 |
| 107 | MP0000858_altered_metastatic_potential | 0.83265072 |
| 108 | MP0005647_abnormal_sex_gland | 0.82502944 |
| 109 | MP0001853_heart_inflammation | 0.82424495 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.82079878 |
| 111 | MP0003693_abnormal_embryo_hatching | 0.81844848 |
| 112 | MP0002166_altered_tumor_susceptibility | 0.81528291 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.81162430 |
| 114 | MP0005390_skeleton_phenotype | 0.80850989 |
| 115 | MP0000490_abnormal_crypts_of | 0.78161378 |
| 116 | MP0002277_abnormal_respiratory_mucosa | 0.77756276 |
| 117 | MP0002933_joint_inflammation | 0.76677064 |
| 118 | MP0002168_other_aberrant_phenotype | 0.76449985 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.76363277 |
| 120 | MP0001849_ear_inflammation | 0.75856800 |
| 121 | MP0000689_abnormal_spleen_morphology | 0.75552178 |
| 122 | MP0002118_abnormal_lipid_homeostasis | 0.75303871 |
| 123 | MP0010352_gastrointestinal_tract_polyps | 0.75206106 |
| 124 | MP0001881_abnormal_mammary_gland | 0.74817598 |
| 125 | MP0000249_abnormal_blood_vessel | 0.73033699 |
| 126 | MP0002653_abnormal_ependyma_morphology | 0.71406183 |
| 127 | MP0002132_abnormal_respiratory_system | 0.70350024 |
| 128 | MP0003795_abnormal_bone_structure | 0.66356932 |
| 129 | MP0004381_abnormal_hair_follicle | 0.64310585 |
| 130 | MP0006054_spinal_hemorrhage | 0.64117263 |
| 131 | MP0002396_abnormal_hematopoietic_system | 0.63603380 |
| 132 | MP0003045_fibrosis | 0.63058513 |
| 133 | MP0009765_abnormal_xenobiotic_induced | 0.63048096 |
| 134 | MP0008874_decreased_physiological_sensi | 0.62645941 |
| 135 | MP0005381_digestive/alimentary_phenotyp | 0.53650296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thrombocytopenia (HP:0001973) | 5.01513924 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.44535012 |
| 3 | Male infertility (HP:0003251) | 4.33040958 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.31643651 |
| 5 | Stomatitis (HP:0010280) | 4.18722368 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.13129869 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.13016022 |
| 8 | Deep venous thrombosis (HP:0002625) | 4.04984418 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.91881718 |
| 10 | Myocardial infarction (HP:0001658) | 3.76367577 |
| 11 | Prostate neoplasm (HP:0100787) | 3.62684318 |
| 12 | Loss of speech (HP:0002371) | 3.36934395 |
| 13 | Keratoconjunctivitis sicca (HP:0001097) | 3.28900290 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 3.27849984 |
| 15 | Complement deficiency (HP:0004431) | 3.21833301 |
| 16 | Meningitis (HP:0001287) | 3.18664320 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.18482314 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.18482314 |
| 19 | Tetraparesis (HP:0002273) | 3.17287092 |
| 20 | Intrahepatic cholestasis (HP:0001406) | 3.10613178 |
| 21 | Hemoptysis (HP:0002105) | 3.09045336 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.08226985 |
| 23 | Obstructive lung disease (HP:0006536) | 3.08226985 |
| 24 | Myositis (HP:0100614) | 3.05932248 |
| 25 | Esophageal varix (HP:0002040) | 3.01881217 |
| 26 | Orchitis (HP:0100796) | 3.01171064 |
| 27 | T lymphocytopenia (HP:0005403) | 3.01004707 |
| 28 | Cortical dysplasia (HP:0002539) | 3.00189975 |
| 29 | Keratoconjunctivitis (HP:0001096) | 2.97040342 |
| 30 | Papillary thyroid carcinoma (HP:0002895) | 2.93300222 |
| 31 | Spontaneous abortion (HP:0005268) | 2.93173583 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 2.92249826 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.91382141 |
| 34 | Abnormality of T cell number (HP:0011839) | 2.90899625 |
| 35 | Encephalitis (HP:0002383) | 2.89416418 |
| 36 | Dysostosis multiplex (HP:0000943) | 2.88151627 |
| 37 | Abnormality of macrophages (HP:0004311) | 2.81369046 |
| 38 | Glomerulonephritis (HP:0000099) | 2.78645001 |
| 39 | Recurrent skin infections (HP:0001581) | 2.76332655 |
| 40 | Increased IgE level (HP:0003212) | 2.74236529 |
| 41 | Xanthomatosis (HP:0000991) | 2.72247990 |
| 42 | Polycythemia (HP:0001901) | 2.69804002 |
| 43 | Peritonitis (HP:0002586) | 2.69509992 |
| 44 | Abnormality of the nasal mucosa (HP:0000433) | 2.66796783 |
| 45 | Hematochezia (HP:0002573) | 2.65994811 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.65279427 |
| 47 | Nephritis (HP:0000123) | 2.65273910 |
| 48 | Nasal polyposis (HP:0100582) | 2.64165405 |
| 49 | Joint hemorrhage (HP:0005261) | 2.63622681 |
| 50 | Mediastinal lymphadenopathy (HP:0100721) | 2.59716758 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.59070424 |
| 52 | Optic neuritis (HP:0100653) | 2.59070424 |
| 53 | Urticaria (HP:0001025) | 2.58614838 |
| 54 | Cellulitis (HP:0100658) | 2.54504623 |
| 55 | Colitis (HP:0002583) | 2.54425625 |
| 56 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.53347110 |
| 57 | Vasculitis (HP:0002633) | 2.50794196 |
| 58 | Chronic otitis media (HP:0000389) | 2.50068436 |
| 59 | Gingival bleeding (HP:0000225) | 2.48864428 |
| 60 | Inflammation of the large intestine (HP:0002037) | 2.48662585 |
| 61 | Increased serum ferritin (HP:0003281) | 2.46750021 |
| 62 | Gastrointestinal inflammation (HP:0004386) | 2.45702949 |
| 63 | Pustule (HP:0200039) | 2.45621105 |
| 64 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.45261578 |
| 65 | Arterial thrombosis (HP:0004420) | 2.42093827 |
| 66 | Acute myeloid leukemia (HP:0004808) | 2.42057496 |
| 67 | Abnormality of complement system (HP:0005339) | 2.40921721 |
| 68 | Gangrene (HP:0100758) | 2.40452314 |
| 69 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.40384596 |
| 70 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.39387844 |
| 71 | Abnormality of the common coagulation pathway (HP:0010990) | 2.37421770 |
| 72 | Hemorrhage of the eye (HP:0011885) | 2.37278915 |
| 73 | Purpura (HP:0000979) | 2.36435353 |
| 74 | Disinhibition (HP:0000734) | 2.35039542 |
| 75 | Recurrent bronchitis (HP:0002837) | 2.32106082 |
| 76 | Pulmonary embolism (HP:0002204) | 2.31685643 |
| 77 | Abnormality of the fingertips (HP:0001211) | 2.31238433 |
| 78 | Chest pain (HP:0100749) | 2.30726430 |
| 79 | Increased IgM level (HP:0003496) | 2.29334665 |
| 80 | Epidermoid cyst (HP:0200040) | 2.28335334 |
| 81 | Petechiae (HP:0000967) | 2.27120421 |
| 82 | Hypoalphalipoproteinemia (HP:0003233) | 2.26704556 |
| 83 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.24552089 |
| 84 | Abnormality of T cells (HP:0002843) | 2.24217681 |
| 85 | Gingivitis (HP:0000230) | 2.22916381 |
| 86 | Osteomyelitis (HP:0002754) | 2.20559994 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.20183190 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.20183190 |
| 89 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.20183190 |
| 90 | Prolonged bleeding time (HP:0003010) | 2.19749332 |
| 91 | Epistaxis (HP:0000421) | 2.18903752 |
| 92 | Interstitial pulmonary disease (HP:0006530) | 2.18415796 |
| 93 | Abnormality of the pleura (HP:0002103) | 2.16706965 |
| 94 | Abnormality of lateral ventricle (HP:0030047) | 2.16494369 |
| 95 | Recurrent viral infections (HP:0004429) | 2.16406093 |
| 96 | Recurrent fungal infections (HP:0002841) | 2.15989903 |
| 97 | Periodontitis (HP:0000704) | 2.15655314 |
| 98 | Basal ganglia calcification (HP:0002135) | 2.15211196 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 2.14102961 |
| 100 | Hypercholesterolemia (HP:0003124) | 2.13838887 |
| 101 | Joint swelling (HP:0001386) | 2.13541968 |
| 102 | Mucopolysacchariduria (HP:0008155) | 2.12829929 |
| 103 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.12829929 |
| 104 | Osteolytic defects of the hand bones (HP:0009699) | 2.11108293 |
| 105 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.11108293 |
| 106 | Cheilitis (HP:0100825) | 2.10221881 |
| 107 | Pulmonary infiltrates (HP:0002113) | 2.10033902 |
| 108 | Gastrointestinal stroma tumor (HP:0100723) | 2.09270891 |
| 109 | Prolonged partial thromboplastin time (HP:0003645) | 2.06162057 |
| 110 | Abnormality of the prostate (HP:0008775) | 2.06109107 |
| 111 | Hypolipoproteinemia (HP:0010981) | 2.04095631 |
| 112 | Sensorimotor neuropathy (HP:0007141) | 2.03984705 |
| 113 | Granulocytopenia (HP:0001913) | 2.03098136 |
| 114 | Hypobetalipoproteinemia (HP:0003563) | 2.02677531 |
| 115 | Abnormality of purine metabolism (HP:0004352) | 2.02133621 |
| 116 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.01542882 |
| 117 | Abnormality of the endocardium (HP:0004306) | 2.01174944 |
| 118 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.01165600 |
| 119 | Thick nail (HP:0001805) | 2.00494304 |
| 120 | Chronic diarrhea (HP:0002028) | 1.99928124 |
| 121 | Episodic fever (HP:0001954) | 1.99555607 |
| 122 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.99216966 |
| 123 | Polyneuropathy (HP:0001271) | 1.99200345 |
| 124 | Glomerulopathy (HP:0100820) | 1.98467272 |
| 125 | Panhypogammaglobulinemia (HP:0003139) | 1.97587670 |
| 126 | Abnormality of glycolipid metabolism (HP:0010969) | 1.97074640 |
| 127 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.97074640 |
| 128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.97074640 |
| 129 | Acne (HP:0001061) | 1.94749935 |
| 130 | Amyloidosis (HP:0011034) | 1.94634766 |
| 131 | Fat malabsorption (HP:0002630) | 1.94232019 |
| 132 | Axonal loss (HP:0003447) | 1.94217270 |
| 133 | Hepatosplenomegaly (HP:0001433) | 1.93928349 |
| 134 | Thrombophlebitis (HP:0004418) | 1.93609711 |
| 135 | Lymphopenia (HP:0001888) | 1.92017118 |
| 136 | Hyperglycemia (HP:0003074) | 1.91242361 |
| 137 | Abnormality of the intrinsic pathway (HP:0010989) | 1.91083736 |
| 138 | Spontaneous hematomas (HP:0007420) | 1.90847984 |
| 139 | Autoimmune hemolytic anemia (HP:0001890) | 1.90292296 |
| 140 | Arthralgia (HP:0002829) | 1.89654383 |
| 141 | Skin ulcer (HP:0200042) | 1.89215163 |
| 142 | Abnormality of the hepatic vasculature (HP:0006707) | 1.88887679 |
| 143 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.87929500 |
| 144 | Vacuolated lymphocytes (HP:0001922) | 1.87464570 |
| 145 | Conjunctival telangiectasia (HP:0000524) | 1.86817889 |
| 146 | Hyperlipoproteinemia (HP:0010980) | 1.86349552 |
| 147 | Pigmentary retinal degeneration (HP:0001146) | 1.85303523 |
| 148 | Leukocytosis (HP:0001974) | 1.84115861 |
| 149 | Arterial tortuosity (HP:0005116) | 1.83095313 |
| 150 | Abnormality of proline metabolism (HP:0010907) | 1.82799840 |
| 151 | Hydroxyprolinuria (HP:0003080) | 1.82799840 |
| 152 | Anorexia (HP:0002039) | 1.82622699 |
| 153 | Hypergammaglobulinemia (HP:0010702) | 1.80048977 |
| 154 | Malnutrition (HP:0004395) | 1.78806619 |
| 155 | Abnormality of nucleobase metabolism (HP:0010932) | 1.77956379 |
| 156 | Porencephaly (HP:0002132) | 1.77050040 |
| 157 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.76073096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 4.70561777 |
| 2 | TAOK3 | 3.93273314 |
| 3 | TYK2 | 2.91986871 |
| 4 | LATS2 | 2.91011473 |
| 5 | MAP3K6 | 2.79535093 |
| 6 | STK38L | 2.73423211 |
| 7 | MAP3K13 | 2.72637440 |
| 8 | PRPF4B | 2.72569753 |
| 9 | KSR2 | 2.59620572 |
| 10 | ERBB4 | 2.58725386 |
| 11 | JAK3 | 2.51133616 |
| 12 | MOS | 2.34938628 |
| 13 | TBK1 | 2.30608412 |
| 14 | STK3 | 2.25492213 |
| 15 | IKBKE | 2.15405008 |
| 16 | MAP3K14 | 2.13131041 |
| 17 | MAP2K3 | 2.05583637 |
| 18 | BMPR2 | 1.85017310 |
| 19 | TXK | 1.80851822 |
| 20 | MAP3K3 | 1.75088820 |
| 21 | TAOK2 | 1.74431987 |
| 22 | ERN1 | 1.70879115 |
| 23 | JAK1 | 1.65366205 |
| 24 | NME2 | 1.60817719 |
| 25 | KIT | 1.60532534 |
| 26 | BTK | 1.60383103 |
| 27 | FGFR4 | 1.58484014 |
| 28 | PLK4 | 1.57747138 |
| 29 | ABL2 | 1.54942758 |
| 30 | MAP3K11 | 1.54676706 |
| 31 | GRK7 | 1.51087701 |
| 32 | FES | 1.47352064 |
| 33 | TRIB3 | 1.46743647 |
| 34 | ARAF | 1.38867309 |
| 35 | SYK | 1.35419345 |
| 36 | TAOK1 | 1.34959600 |
| 37 | MAP3K9 | 1.33635652 |
| 38 | RAF1 | 1.32870558 |
| 39 | PBK | 1.27361448 |
| 40 | STK10 | 1.27178532 |
| 41 | ACVR1B | 1.23021225 |
| 42 | CDC42BPA | 1.21763462 |
| 43 | LCK | 1.17009608 |
| 44 | EPHA3 | 1.16992099 |
| 45 | TEC | 1.16954587 |
| 46 | NEK9 | 1.16571597 |
| 47 | IKBKB | 1.16355162 |
| 48 | LYN | 1.16173732 |
| 49 | SIK3 | 1.14078587 |
| 50 | TNK2 | 1.13284088 |
| 51 | ITK | 1.12817021 |
| 52 | JAK2 | 1.09273181 |
| 53 | CHUK | 1.09257771 |
| 54 | GRK6 | 1.08594731 |
| 55 | EEF2K | 1.07561938 |
| 56 | MST1R | 1.07394887 |
| 57 | CDK8 | 1.04578580 |
| 58 | CDK9 | 1.04145667 |
| 59 | NEK2 | 1.00804295 |
| 60 | RPS6KA4 | 0.99100463 |
| 61 | MELK | 0.98198806 |
| 62 | PRKD3 | 0.96277808 |
| 63 | MAP3K5 | 0.95254242 |
| 64 | CDK12 | 0.95090401 |
| 65 | NLK | 0.93796846 |
| 66 | RIPK4 | 0.92375701 |
| 67 | FGFR3 | 0.92078562 |
| 68 | IRAK1 | 0.91766697 |
| 69 | DMPK | 0.89128836 |
| 70 | EPHB1 | 0.87414279 |
| 71 | BRAF | 0.86823774 |
| 72 | CDC7 | 0.86372858 |
| 73 | MAPK11 | 0.85997043 |
| 74 | PKN2 | 0.85797349 |
| 75 | RIPK1 | 0.84352512 |
| 76 | RET | 0.83935978 |
| 77 | IRAK4 | 0.80171417 |
| 78 | TTK | 0.79576415 |
| 79 | PRKAA2 | 0.76335849 |
| 80 | ABL1 | 0.76259787 |
| 81 | NUAK1 | 0.73465827 |
| 82 | BLK | 0.73435714 |
| 83 | MUSK | 0.73245352 |
| 84 | CSK | 0.72592424 |
| 85 | PDPK1 | 0.71104721 |
| 86 | CAMK1D | 0.69907193 |
| 87 | IRAK3 | 0.68516443 |
| 88 | PDK1 | 0.68453024 |
| 89 | PIM1 | 0.68111260 |
| 90 | MAPKAPK3 | 0.67764284 |
| 91 | IRAK2 | 0.66027736 |
| 92 | MAP3K1 | 0.66010152 |
| 93 | SMG1 | 0.65755735 |
| 94 | DDR2 | 0.65273865 |
| 95 | MAP3K8 | 0.64485609 |
| 96 | ZAP70 | 0.64184717 |
| 97 | BMX | 0.63491306 |
| 98 | FRK | 0.59368880 |
| 99 | MARK2 | 0.58931401 |
| 100 | TGFBR2 | 0.57086977 |
| 101 | CDK4 | 0.55975925 |
| 102 | DYRK2 | 0.53914815 |
| 103 | YES1 | 0.53568435 |
| 104 | PTK6 | 0.53256617 |
| 105 | PIM2 | 0.52911831 |
| 106 | CHEK2 | 0.52850149 |
| 107 | FLT3 | 0.52809261 |
| 108 | STK4 | 0.52641296 |
| 109 | STK24 | 0.52620229 |
| 110 | TESK2 | 0.51816373 |
| 111 | PRKAA1 | 0.50978127 |
| 112 | MAP4K1 | 0.50515089 |
| 113 | STK38 | 0.49459247 |
| 114 | MAP2K6 | 0.48544669 |
| 115 | MAPK7 | 0.45883401 |
| 116 | FGR | 0.45710864 |
| 117 | TRPM7 | 0.44924004 |
| 118 | FYN | 0.41817238 |
| 119 | CDK6 | 0.41522485 |
| 120 | TYRO3 | 0.40630536 |
| 121 | PTK2 | 0.37979301 |
| 122 | CSF1R | 0.37719929 |
| 123 | TIE1 | 0.37278821 |
| 124 | MAP3K10 | 0.36544159 |
| 125 | HCK | 0.36467366 |
| 126 | LRRK2 | 0.36040380 |
| 127 | HIPK2 | 0.35429471 |
| 128 | PRKCQ | 0.35169463 |
| 129 | MAPKAPK2 | 0.34915140 |
| 130 | PDGFRB | 0.33875179 |
| 131 | MARK3 | 0.33673209 |
| 132 | SIK2 | 0.33157006 |
| 133 | RPS6KC1 | 0.33106163 |
| 134 | RPS6KL1 | 0.33106163 |
| 135 | MATK | 0.31361525 |
| 136 | CAMKK2 | 0.30681806 |
| 137 | CLK1 | 0.30183316 |
| 138 | PRKD2 | 0.30129623 |
| 139 | KSR1 | 0.28086985 |
| 140 | TTN | 0.27480531 |
| 141 | EGFR | 0.27125784 |
| 142 | SIK1 | 0.25675796 |
| 143 | MAPK12 | 0.25607750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.97383959 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.28370747 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.22154437 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.13245173 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.07163374 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.06500858 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.00652791 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.99026333 |
| 9 | Influenza A_Homo sapiens_hsa05164 | 1.96198882 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87546592 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.82231058 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.75733997 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.74053721 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69874297 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67591869 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.66502235 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.64426057 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.64083841 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.63139578 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59742842 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.56751529 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55160810 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.52080581 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43380619 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43142716 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.42996963 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.41356687 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.41098277 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.39268550 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38279305 |
| 31 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.28920746 |
| 32 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.22646931 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.22527491 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.22414944 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.19648147 |
| 36 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.19253145 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.19223513 |
| 38 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.15696882 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10341376 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.09854704 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09497549 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.05565145 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.03656416 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00909344 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 0.98025764 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.95813868 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 0.95757697 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94144975 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.94038081 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93757703 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.90936493 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85502029 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85475800 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82815182 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82809802 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82419314 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80332630 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.79648898 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79180519 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78464237 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77408223 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.76735377 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76472695 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76267137 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76174993 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.74869776 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74760209 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72714997 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71785344 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70995020 |
| 71 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70027289 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69973233 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69939386 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69167486 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68819830 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68031058 |
| 77 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.67857967 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.67571626 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66779935 |
| 80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66763924 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66592495 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65607411 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.63106029 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.60430196 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.59844328 |
| 86 | Cell cycle_Homo sapiens_hsa04110 | 0.59027139 |
| 87 | Asthma_Homo sapiens_hsa05310 | 0.58465777 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.57274517 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.57071115 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56262067 |
| 91 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56084932 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.55240296 |
| 93 | Adherens junction_Homo sapiens_hsa04520 | 0.54981171 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53940240 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53933758 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53908487 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53379722 |
| 98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53072538 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51635398 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50880002 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50847248 |
| 102 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50197237 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49789495 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49276314 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49021000 |
| 106 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.48848999 |
| 107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47930111 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47816697 |
| 109 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47555675 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.47231576 |
| 111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47201277 |
| 112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46776503 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45697842 |
| 114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45088327 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44622678 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | 0.43223882 |
| 117 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.42809288 |
| 118 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42346667 |
| 119 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42258874 |
| 120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42151659 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40254032 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39834104 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39311692 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.37608430 |
| 125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36350250 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36064628 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35397921 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35024726 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32769899 |
| 130 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29774049 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29500133 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29093082 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28056666 |
| 134 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25703783 |
| 135 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21584899 |
| 136 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20638076 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.19578191 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18286224 |
| 139 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.18062221 |
| 140 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.16297311 |

